Article Text

PDF
Addition of immunosuppression to comprehensive supportive care did not benefit patients with IgA nephropathy
  1. Alexander D Lalayiannis
  1. Nephrology Department, Birmingham Children's Hospital, Birmingham, UK
  1. Correspondence to Dr Alexander D Lalayiannis, Nephrology Department, Birmingham Children's Hospital, Birmingham, UK; alexander.lalayiannis{at}nhs.net

Statistics from Altmetric.com

Study question

Setting: Patients recruited from 32 nephrology centres in Germany.

Patients: Any patient aged 18–70 years, with confirmed IgA nephropathy on biopsy, with proteinuria (>0.75 g/day), and hypertension (>139/89 mm Hg) or impaired renal function (estimated glomerular filtration rate end stage renal failure (eGFR) <90 mL/min/1.73 m2) or both.

Intervention: All patients joining the study had an initial 6 months ‘run-in’ period during which they received smoking cessation, non-steroidal anti-inflammatory drug avoidance, dietary advice and statins to reduce cholesterol to <5.2 mmol/L; and ACE inhibitor or angiotensin receptor blocker, to reduce proteinuria and hypertension.

If the proteinuria persisted (>0.75 and <3.5 g/day), participants were randomised to supportive treatment or one …

Correspondence to Dr Alexander D Lalayiannis, Nephrology Department, Birmingham Children's Hospital, Birmingham B4 6NH, UK; alexander.lalayiannis{at}nhs.net

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.